Related Experiment Video
Updated: Aug 9, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Identifying potential core genes for chronic obstructive pulmonary disease associated with cocaine exposure via
Wei Luo1, Ming-Ke He2, Mao-Run Guo3
1School of Health and Wellness & School of Medicine, Sichuan University of Arts and Science, Dazhou, Sichuan 635000, People's Republic of China.
Abstract:
Cocaine abuse can damage various organ systems; however, the molecular mechanisms underlying its potential contribute to chronic obstructive pulmonary disease (COPD) remain poorly understood. In this study, an integrative computational framework was used to investigate the molecular links between cocaine exposure and COPD and to identify potential key targets and regulatory mechanisms. Cocaine‑associated targets and COPD‑related differentially expressed genes (DEGs) were collected from public databases and transcriptomic datasets, yielding 34 overlapping DEGs that may be associated with both cocaine exposure and COPD. Functional enrichment and protein-protein interaction network analyses indicated that DEGs were mainly involved in cancer-, inflammation-, and virus-related pathways. Three machine learning algorithms combined with network topology analysis identified cathepsin D (CTSD) as a core target associated with multiple immune cell types. Single-cell RNA sequencing analysis further showed that CTSD is highly expressed in macrophages. Virtual knockout analysis using scTenifoldKnk identified 113 consistently responsive genes, which were functionally enriched in autoimmune reactions, infection-induced immune activation, and antigen presentation pathways. Molecular docking and molecular dynamics simulations demonstrated strong binding affinity and stable interactions between cocaine and CTSD, supporting a potential mechanistic role in COPD related to cocaine exposure. Additionally, ten CTSD-associated drugs were identified from DSigDB and evaluated using molecular docking, pharmacokinetic analysis, and druglikeness assessment. Collectively, this study highlights CTSD as a candidate molecular target linking cocaine exposure to COPD and provides a theoretical basis for future experimental and toxicological investigations.
Insights
Cocaine use may contribute to chronic obstructive pulmonary disease (COPD) by affecting cathepsin D (CTSD). This study identifies CTSD as a key molecular target linking cocaine exposure to COPD, offering a basis for further research.
Area of Science:
- Computational biology
- Toxicology
- Pulmonology
Background:
- Cocaine abuse is linked to organ damage, but its connection to chronic obstructive pulmonary disease (COPD) is unclear.
- Molecular mechanisms linking cocaine exposure to COPD pathogenesis require elucidation.
Purpose of the Study:
- To investigate molecular links between cocaine exposure and COPD using an integrative computational framework.
- To identify key molecular targets and regulatory mechanisms involved in cocaine-induced COPD.
Main Methods:
- Collected and analyzed cocaine-associated targets and COPD-related differentially expressed genes (DEGs).
- Utilized functional enrichment, protein-protein interaction networks, and machine learning algorithms.
- Performed single-cell RNA sequencing, virtual knockout analysis, molecular docking, and molecular dynamics simulations.
Main Results:
- Identified 34 overlapping DEGs between cocaine exposure and COPD, enriched in cancer, inflammation, and virus pathways.
- Highlighted cathepsin D (CTSD) as a core target highly expressed in macrophages, potentially linking cocaine and COPD.
- Demonstrated strong binding affinity between cocaine and CTSD, suggesting a mechanistic role and identifying potential therapeutic drugs.
Conclusions:
- CTSD is a candidate molecular target connecting cocaine exposure to COPD.
- This study provides a theoretical foundation for experimental and toxicological investigations into cocaine-related COPD.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Toxicity: Risk factors